Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Kerr, M. Curran, J. Moore, D. Erdman, P. Coyle, T. Nunoue, D. Middleton, W. Ferguson (1995)
Genetic diversity in the non-structural gene of parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing.Journal of virological methods, 53 2-3
Daniel Legendre, J. Rommelaere (1992)
Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibitionJournal of Virology, 66
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
Attwater Hl (1948)
Surgery of urethral stricture.BMJ, 2
J. Clewley (1989)
Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimensJournal of Clinical Microbiology, 27
G. Kurtzman, P. Meyers, B. Cohen, Adoor Amunullah, N. Young (1988)
PERSISTENT B19 PARVOVIRUS INFECTION AS A CAUSE OF SEVERE CHRONIC ANAEMIA IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKAEMIAThe Lancet, 332
Hiroyuki Sato, F. Takakura, E. Kojima, K. Fukada, K. Okochi, Y. Maeda (1995)
Screening of blood donors for human parvovirus B19The Lancet, 346
A. Azzi, S. Ciappi, K. Zakvrzewska, M. Morfini, G. Mariani, P. Mannucci (1992)
Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentratesAmerican Journal of Hematology, 39
X. Li, S. Rhode (1991)
Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in vitro.Virology, 184 1
M. Anderson, M. Anderson, S. Jones, A. Minson (1985)
Diagnosis of human parvovirus infection by dot‐blot hybridization using cloned viral DNAJournal of Medical Virology, 15
W. Koch, S. Adler (1990)
Detection of human parvovirus B19 DNA by using the polymerase chain reactionJournal of Clinical Microbiology, 28
Clewley Jp (1985)
Detection of human parvovirus using a molecularly cloned probe.Journal of Medical Virology, 15
Schnitzer Schnitzer, Penmetcha Penmetcha (1996)
Viral arthritisCurr Opin Rheumatol, 8
M. Skiadopoulos, E. Faust (1993)
Mutational analysis of conserved tyrosines in the NS-1 protein of the parvovirus minute virus of mice.Virology, 194 2
F. Mcomish, P. Yap, A. Jordan, H. Hart, B. Cohen, P. Simmonds (1993)
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionJournal of Clinical Microbiology, 31
C. Jones (1963)
REGIONAL CURARISATION. ANAESTHESIA FOR SURGERY OF THE KNEE-JOINT.Lancet, 2 7306
Serjeant Serjeant, Topley Topley, Mason Mason, Serjeant Serjeant, Pattison Pattison, Jones Jones, Mohamed Mohamed (1981)
Outbreak of aplastic crisis in sickle cell anemia associated with parvovirus‐like agentLancet, 2
Nathalie Sol, Frédéric Morinet, Marc Alizon, Uriel Hazan (1993)
Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.The Journal of general virology, 74 ( Pt 9)
V. Deiss, J. Tratschin, M. Weitz, G. Siegl (1990)
Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini.Virology, 175 1
K. Ozawa, J. Ayub, S. Kajigaya, T. Shimada, N. Young (1988)
The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cellsJournal of Virology, 62
Morey (1995)
10.1007/BF00164171Histochem J, 27
P. Knott, G. Welply, M. Anderson (1984)
Serologically proved intrauterine infection with parvovirus.British Medical Journal (Clinical research ed.), 289
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
J. Lefrère, M. Mariotti, M. Thauvin (1994)
B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentratesThe Lancet, 343
Morey Morey, Ferguson Ferguson, Fleming Fleming (1995)
Combined immunocytochemistry and non‐isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infectionHistochem J, 27
M. Leruez, Coralie Pallier, Isabelle Vassias, J. Elouet, P. Romeo, Frédéric Morinet (1994)
Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization.The Journal of general virology, 75 ( Pt 6)
Kimura Kimura (1995)
Surveillance for infectious disease Japan: the estimation for infectious diseaseNikkei Medical (Japan), 321
Doris Taylor, P. Hochstein (1975)
POTENTIAL VARIANTS OF PHENYLKETONURIAThe Lancet, 305
A. Poblotzki, A. Hemauer, A. Gigler, E. Puchhammer-Stöckl, F. Heinz, J. Pont, K. Laczika, H. Wolf, S. Modrow (1995)
Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.The Journal of infectious diseases, 172 5
S. Kajigaya, T. Shimada, S. Fujita, N. Young (1989)
A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.Proceedings of the National Academy of Sciences of the United States of America, 86 19
A. Anand, E. Gray, T. Brown, J. Clewley, B. Cohen (1987)
Human parvovirus infection in pregnancy and hydrops fetalis.The New England journal of medicine, 316 4
Copland Jg, Davies Ct (1964)
SPREAD OF VIRUS HEPATITIS.The Lancet, 1
K. Umene, T. Nunoue (1990)
The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: a correlation between genome type and prevalence.The Journal of general virology, 71 ( Pt 4)
A. Poblotzki, A. Gigler, B. Lang, H. Wolf, S. Modrow (1995)
Antibodies to parvovirus B19 NS-1 protein in infected individuals.The Journal of general virology, 76 ( Pt 3)
Y. Cossart, B. Cant, A. Field, D. Widdows (1975)
PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 305
K. Yoshimoto, S. Rosenfeld, N. Frickhofen, D. Kennedy, R. Hills, S. Kajigaya, N. Young (1991)
A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune responseJournal of Virology, 65
L. Coulombel, F. Morinet, F. Miélot, G. Tchernia, A. Knisely, P. Shlossman, J. Davidson, B. Gibson, A. Gibson, T. Evans (1989)
PARVOVIRUS INFECTION, LEUKAEMIA, AND IMMUNODEFICIENCYThe Lancet, 333
J. Pattison, S. Jones, J. Hodgson, L. Davis, J. White, C. Stroud, L. Murtaza (1981)
PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIAThe Lancet, 317
R. Shade, M. Blundell, S. Cotmore, P. Tattersall, C. Astell (1986)
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisisJournal of Virology, 58
P. Mortimer (1983)
Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent.Journal of Clinical Pathology, 36
B. Cohen, P. Mortimer, M. Pereira (1983)
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV)Journal of Hygiene, 91
Anand (1987)
10.1056/NEJM198701223160403N Engl J Med, 316
D. Reid, T. Brown, T. Reid, J. Rennie, C. Eastmond (1985)
HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTIONThe Lancet, 325
S. Rosenfeld, K. Yoshimoto, S. Kajigaya, S. Anderson, N. Young, A. Field, P. Warrener, G. Bansal, M. Collett (1992)
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.The Journal of clinical investigation, 89 6
P. Caillet-Fauquet, M. Perros, M. Perros, Anne-Nicole Brandenburger, P. Spegelaere, J. Rommelaere (1990)
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non‐structural proteins.The EMBO Journal, 9
M. Blundell, C. Beard, C. Astell (1987)
In vitro identification of a B19 parvovirus promoter.Virology, 157 2
Cohen Cohen, Mortimer Mortimer, Pereira Pereira (1983)
Diagnostic assays with monoclonal antibodies for serum parvovirus‐like virus (SPLV)J Hyg (Lond), 91
K. Yamashita, Yasuko Matsunaga, Jean Taylor-Wiedeman, Shudo Yamazaki (1992)
A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade.Japanese journal of medical science & biology, 45 2
B. Schwartz (1976)
Letter: Ondine's curse.Lancet, 2 7987
Xinghui Li, S. Rhode (1990)
Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions for viral DNA replication, late promoter trans activation, and cytotoxicityJournal of Virology, 64
Schnitzer (1996)
10.1097/00002281-199607000-00011Curr Opin Rheumatol, 8
O. Corsi, A. Azzi, M. Morfini, R. Fanci, P. Ferrini (1988)
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 25
K. Rao, A. Patel, M. Anderson, J. Hodgson, S. Jones, J. Pattison (1983)
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia.Annals of internal medicine, 98 6
M. Anderson, S. Jones, S. Fisher-Hoch, E. Lewis, S. Hall, C. Bartlett, B. Cohen, P. Mortimer, M. Pereira (1983)
HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?The Lancet, 321
G. Kurtzman, K. Ozawa, B. Cohen, G. Hanson, R. Oseas, N. Young (1987)
Chronic bone marrow failure due to persistent B19 parvovirus infection.The New England journal of medicine, 317 5
H. Sato, J. Hirata, N. Kuroda, H. Shiraki, Y. Maeda, K. Okochi (1991)
Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodiesJournal of Virology, 65
J. Duncan, J. Duncan, J. Duncan, M. Cappellini, M. Cappellini, M. Cappellini, M. Anderson, M. Anderson, M. Anderson, C. Potter, C. Potter, C. Potter, J. Kurtz, J. Kurtz, J. Kurtz, D. Weatherall, D. Weatherall, D. Weatherall (1983)
APLASTIC CRISIS DUE TO PARVOVIRUS INFECTION IN PYRUVATE KINASE DEFICIENCYThe Lancet, 322
The nucleotide sequence of 10 isolates of human parvovirus B19 (B19) were determined and compared throughout 96.3% of the open reading frames (4145 nucleotides from nt. 509–4653). In the 4145 nucleotides, 122 mutation sites were found, of which 24 were accompanied by amino acid displacement. Furthermore, the polymorphism of the amino acids was seen in about 110 bases near the carboxy terminal of the non‐structural protein, ranging from nt. 2011 to 2123, where four amino acid mutation points were found to exist. Based on the amino acid polymorphism of these four mutation sites in this area, 10 isolates of the B19 parvovirus could be divided into 4 subtypes (subtypes A, B, C, and D). The frequency of isolation of the subtypes depended on the time and location of collection of the B19 viremic blood specimens. J. Med. Virol. 62:60–69, 2000. © 2000 Wiley‐Liss, Inc.
Journal of Medical Virology – Wiley
Published: Sep 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.